Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 9,051–9,054 of 9,054 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02259556	CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas(CART30)	recruiting	Phase 1 / Phase 2	30	Chinese PLA General HospitalOTHER	1	Jan 28, 2016	clinicaltrials
NCT02497898	Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma	not yet recruiting	Phase 2	1,000	The First People's Hospital of ChangzhouOTHER	0	Jul 15, 2015